Ludvig Balteskard Rinde
@lbrinde.bsky.social
Kidney nerd in the Arctic!
Associate Professor/Resident, University Hospital of North Norway/University in Tromsø
Broad interests; from AKI and critical care to CKD and prevention.
Biggest achievement: Top Resident Score #nephmadness 2024
🤓🏔️
Associate Professor/Resident, University Hospital of North Norway/University in Tromsø
Broad interests; from AKI and critical care to CKD and prevention.
Biggest achievement: Top Resident Score #nephmadness 2024
🤓🏔️
The annual #NephMadnessParty in Tromso, Norway 🥳 Between kidney cookies, rhubarb drinks, and licorice, we agreed that CAR-T is this year's #nephmadness winner 🏆 #arctic-cart
March 21, 2025 at 7:19 PM
The annual #NephMadnessParty in Tromso, Norway 🥳 Between kidney cookies, rhubarb drinks, and licorice, we agreed that CAR-T is this year's #nephmadness winner 🏆 #arctic-cart
Reposted by Ludvig Balteskard Rinde
March 1, 2025 at 2:37 PM
Reposted by Ludvig Balteskard Rinde
Happy #NephMadness Day!
The 8 regions of #NephMadness 2025 have been revealed on the #AJKDBlog. If you're a #NephMadnessNewbie, we explain everything here: buff.ly/DCZDRfN
Looking forward to the fun and learning with all of you!
The 8 regions of #NephMadness 2025 have been revealed on the #AJKDBlog. If you're a #NephMadnessNewbie, we explain everything here: buff.ly/DCZDRfN
Looking forward to the fun and learning with all of you!
Welcome to #NephMadness 2025
Here it is, the 13th edition of NephMadness! Whether you’re new to the competition or just want to relive past glories, we have all the info you need for NephMadness 2025: What is NephMadnes…
buff.ly
March 1, 2025 at 1:36 PM
Happy #NephMadness Day!
The 8 regions of #NephMadness 2025 have been revealed on the #AJKDBlog. If you're a #NephMadnessNewbie, we explain everything here: buff.ly/DCZDRfN
Looking forward to the fun and learning with all of you!
The 8 regions of #NephMadness 2025 have been revealed on the #AJKDBlog. If you're a #NephMadnessNewbie, we explain everything here: buff.ly/DCZDRfN
Looking forward to the fun and learning with all of you!
Reposted by Ludvig Balteskard Rinde
RESOLVE design: www.georgeinstitute.org/projects/ran...
Randomised Evaluation of Sodium Dialysate Levels on Vascular Events (RESOLVE) | The George Institute for Global Health
Chronic kidney disease is increasing globally in line with the rise in the prevalence of diabetes, high blood pressure and obesity, and falls in acute illness mortality. Life can be sustained for thos...
www.georgeinstitute.org
February 11, 2025 at 7:20 AM
RESOLVE design: www.georgeinstitute.org/projects/ran...
Preparing a presentation on HF in HD patients, focusing on sodium levels in dialysate. Low Na (<138) reduces IDWG and MAP, leading to decreased UF, which lowers the risk of intradialytic hypotension and myocardial stunning. What's the standard approach in #Nephsky: low or normal Na levels? #askrenal
February 10, 2025 at 12:05 PM
Preparing a presentation on HF in HD patients, focusing on sodium levels in dialysate. Low Na (<138) reduces IDWG and MAP, leading to decreased UF, which lowers the risk of intradialytic hypotension and myocardial stunning. What's the standard approach in #Nephsky: low or normal Na levels? #askrenal
Reposted by Ludvig Balteskard Rinde
Proposed age-adjusted eGFR thresholds for CKD 👇
#Nephpearls #NephSky
eGFR 75 for ages <40 years
eGFR 60 for 40-65 years
eGFR 45 for >65 years
👉 link.springer.com/book/10.1007...
👉 pubmed.ncbi.nlm.nih.gov/31506289/
#Nephpearls #NephSky
eGFR 75 for ages <40 years
eGFR 60 for 40-65 years
eGFR 45 for >65 years
👉 link.springer.com/book/10.1007...
👉 pubmed.ncbi.nlm.nih.gov/31506289/
January 10, 2025 at 3:26 PM
Proposed age-adjusted eGFR thresholds for CKD 👇
#Nephpearls #NephSky
eGFR 75 for ages <40 years
eGFR 60 for 40-65 years
eGFR 45 for >65 years
👉 link.springer.com/book/10.1007...
👉 pubmed.ncbi.nlm.nih.gov/31506289/
#Nephpearls #NephSky
eGFR 75 for ages <40 years
eGFR 60 for 40-65 years
eGFR 45 for >65 years
👉 link.springer.com/book/10.1007...
👉 pubmed.ncbi.nlm.nih.gov/31506289/
Does anyone have experience with RTX in the maintenance treatment of steroid-dependent NS due to MCD/FSGS? 60-year-old 👴 with complete remission. Could stop prednisolone completely. Now, 4 rounds with RTX (6-month intervals). Is it safe to stop RTX and closely follow up? #askrenal
December 4, 2024 at 3:07 PM
Does anyone have experience with RTX in the maintenance treatment of steroid-dependent NS due to MCD/FSGS? 60-year-old 👴 with complete remission. Could stop prednisolone completely. Now, 4 rounds with RTX (6-month intervals). Is it safe to stop RTX and closely follow up? #askrenal
Reposted by Ludvig Balteskard Rinde
Our group does research on the technique, and we were pleasantly surprised to find out it holds up in TR patients (paper coming soon!). Still big ? about cirrhosis, positive pressure ventilation, CKD/ESRD. And then there’s the issue that it was only really built to predict cardio renal aki.
December 4, 2024 at 12:16 PM
Our group does research on the technique, and we were pleasantly surprised to find out it holds up in TR patients (paper coming soon!). Still big ? about cirrhosis, positive pressure ventilation, CKD/ESRD. And then there’s the issue that it was only really built to predict cardio renal aki.
Reposted by Ludvig Balteskard Rinde
The BPROAD visual abstracts are live
www.nephjc.com/news/bproad
Nice work from @kajareeg.bsky.social with Spanish version @dramiliflores.bsky.social
#NephJC #NephSky
www.nephjc.com/news/bproad
Nice work from @kajareeg.bsky.social with Spanish version @dramiliflores.bsky.social
#NephJC #NephSky
December 3, 2024 at 4:48 PM
The BPROAD visual abstracts are live
www.nephjc.com/news/bproad
Nice work from @kajareeg.bsky.social with Spanish version @dramiliflores.bsky.social
#NephJC #NephSky
www.nephjc.com/news/bproad
Nice work from @kajareeg.bsky.social with Spanish version @dramiliflores.bsky.social
#NephJC #NephSky
Reposted by Ludvig Balteskard Rinde
➡️ Up next on #NephJC #NephSky 🦋
Join us for some high pressure discussion on Dec 3,4 as we discuss #BPROAD from #NEJM
nejm.org/doi/abs/10.1...
Tweetorial by @drpallaviprasad.bsky.social
Join us for some high pressure discussion on Dec 3,4 as we discuss #BPROAD from #NEJM
nejm.org/doi/abs/10.1...
Tweetorial by @drpallaviprasad.bsky.social
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | NEJM
Effective targets for systolic blood-pressure control in patients with type 2 diabetes
are unclear. We enrolled patients 50 years of age or older with type 2 diabetes, elevated
systolic blood press...
nejm.org
December 2, 2024 at 2:41 AM
➡️ Up next on #NephJC #NephSky 🦋
Join us for some high pressure discussion on Dec 3,4 as we discuss #BPROAD from #NEJM
nejm.org/doi/abs/10.1...
Tweetorial by @drpallaviprasad.bsky.social
Join us for some high pressure discussion on Dec 3,4 as we discuss #BPROAD from #NEJM
nejm.org/doi/abs/10.1...
Tweetorial by @drpallaviprasad.bsky.social
So, the complement system plays a major role in lupus nephritis, and I know eculizumab can be effective in the ICU with LN flair. Is there any ongoing RCT investigating an oral complement inhibitor in LN? Could avacopan be an alternative to CNI or belimumab? C5a levels are up in sle #askrenal
December 2, 2024 at 6:54 PM
So, the complement system plays a major role in lupus nephritis, and I know eculizumab can be effective in the ICU with LN flair. Is there any ongoing RCT investigating an oral complement inhibitor in LN? Could avacopan be an alternative to CNI or belimumab? C5a levels are up in sle #askrenal
Reposted by Ludvig Balteskard Rinde
Honey, stop what you're doing, new hyponatremia research just dropped!
What's it say?
It looks like slow correction is associated with worse outcomes, like death and length of stay!
Was it just a small study?
No, it was a meta-analysis of almost 12,000 patients!
jamanetwork.com/journals/jam...
What's it say?
It looks like slow correction is associated with worse outcomes, like death and length of stay!
Was it just a small study?
No, it was a meta-analysis of almost 12,000 patients!
jamanetwork.com/journals/jam...
Correction Rates and Clinical Outcomes in Hospitalized Adults With Severe Hyponatremia
This systematic review and meta-analysis evaluates the association of sodium correction rates with mortality among hospitalized adults with severe hyponatremia.
jamanetwork.com
November 19, 2024 at 4:51 AM
Honey, stop what you're doing, new hyponatremia research just dropped!
What's it say?
It looks like slow correction is associated with worse outcomes, like death and length of stay!
Was it just a small study?
No, it was a meta-analysis of almost 12,000 patients!
jamanetwork.com/journals/jam...
What's it say?
It looks like slow correction is associated with worse outcomes, like death and length of stay!
Was it just a small study?
No, it was a meta-analysis of almost 12,000 patients!
jamanetwork.com/journals/jam...
Reposted by Ludvig Balteskard Rinde
Achieved BP in the control group for BPROAD was 133. So it really did compare (nearly) guideline therapy vs even lower
"At 1 year, the mean SBP was 121.6 mm Hg (median, 118.3 mm Hg) in the intensive-treatment group and 133.2 mm Hg (median, 135.0 mm Hg) in the standard-treatment group."
"At 1 year, the mean SBP was 121.6 mm Hg (median, 118.3 mm Hg) in the intensive-treatment group and 133.2 mm Hg (median, 135.0 mm Hg) in the standard-treatment group."
November 18, 2024 at 1:23 PM
Achieved BP in the control group for BPROAD was 133. So it really did compare (nearly) guideline therapy vs even lower
"At 1 year, the mean SBP was 121.6 mm Hg (median, 118.3 mm Hg) in the intensive-treatment group and 133.2 mm Hg (median, 135.0 mm Hg) in the standard-treatment group."
"At 1 year, the mean SBP was 121.6 mm Hg (median, 118.3 mm Hg) in the intensive-treatment group and 133.2 mm Hg (median, 135.0 mm Hg) in the standard-treatment group."
Shouldn't the next BP target study compare targeting an SBP less than 120 mmHg or less than 130 mmHg? ESPRIT and BPROAD both compared 120 vs 140, but most guidelines recommend below 130 🤔 #askrenal
www.nejm.org/doi/full/10....
www.nejm.org/doi/full/10....
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | NEJM
Effective targets for systolic blood-pressure control in patients with type 2 diabetes
are unclear. We enrolled patients 50 years of age or older with type 2 diabetes, elevated
systolic blood press...
www.nejm.org
November 18, 2024 at 9:41 AM
Shouldn't the next BP target study compare targeting an SBP less than 120 mmHg or less than 130 mmHg? ESPRIT and BPROAD both compared 120 vs 140, but most guidelines recommend below 130 🤔 #askrenal
www.nejm.org/doi/full/10....
www.nejm.org/doi/full/10....
Just discovered nephronpower (I know I'm late to the party..) what a resource 🙌 hat tip to @kdjhaveri.bsky.social
November 17, 2024 at 10:02 PM
Just discovered nephronpower (I know I'm late to the party..) what a resource 🙌 hat tip to @kdjhaveri.bsky.social
Reposted by Ludvig Balteskard Rinde
Very nice overview of the current state of affairs in cardiogenic shock (published this week in @TheLancet):
November 17, 2024 at 2:27 AM
Very nice overview of the current state of affairs in cardiogenic shock (published this week in @TheLancet):
Reposted by Ludvig Balteskard Rinde
Further sprinting towards intensive blood pressure lowering in TD2 👍🏻
Guess what the kidney outcomes look like…
#BROAD RCT presented at #AHA24 and in NEJM 👇
www.nejm.org/doi/full/10....
Guess what the kidney outcomes look like…
#BROAD RCT presented at #AHA24 and in NEJM 👇
www.nejm.org/doi/full/10....
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | NEJM
Effective targets for systolic blood-pressure control in patients with type 2 diabetes
are unclear. We enrolled patients 50 years of age or older with type 2 diabetes, elevated
systolic blood press...
www.nejm.org
November 16, 2024 at 5:43 PM
Further sprinting towards intensive blood pressure lowering in TD2 👍🏻
Guess what the kidney outcomes look like…
#BROAD RCT presented at #AHA24 and in NEJM 👇
www.nejm.org/doi/full/10....
Guess what the kidney outcomes look like…
#BROAD RCT presented at #AHA24 and in NEJM 👇
www.nejm.org/doi/full/10....
Reposted by Ludvig Balteskard Rinde
What happens if you change from NaCl 0.9% to Dextrose G5% solution as universal drug solvent on icu? Less hypernatriemia! So proud that this is out!
academic.oup.com/ckj/advance-...
academic.oup.com/ckj/advance-...
November 13, 2024 at 4:36 PM
What happens if you change from NaCl 0.9% to Dextrose G5% solution as universal drug solvent on icu? Less hypernatriemia! So proud that this is out!
academic.oup.com/ckj/advance-...
academic.oup.com/ckj/advance-...
Reposted by Ludvig Balteskard Rinde
Hi #Xtwitter #NephTwitter #SkyTwitter
Many in the #Nephrology community are migrating to #BlueSky
Looks enticing, big names are on their way, @kireports will expand our footprint too!
Here is a little starter-pack to get started, thanks #NephJC
twitter.com/NephJC/s...
Many in the #Nephrology community are migrating to #BlueSky
Looks enticing, big names are on their way, @kireports will expand our footprint too!
Here is a little starter-pack to get started, thanks #NephJC
twitter.com/NephJC/s...
November 12, 2024 at 11:12 PM
Hi #Xtwitter #NephTwitter #SkyTwitter
Many in the #Nephrology community are migrating to #BlueSky
Looks enticing, big names are on their way, @kireports will expand our footprint too!
Here is a little starter-pack to get started, thanks #NephJC
twitter.com/NephJC/s...
Many in the #Nephrology community are migrating to #BlueSky
Looks enticing, big names are on their way, @kireports will expand our footprint too!
Here is a little starter-pack to get started, thanks #NephJC
twitter.com/NephJC/s...